Ingenia Therapeutics Inc. (KOSDAQ:950260)
South Korea · Delayed Price · Currency is KRW 18,000
+650 (3.75%)
At close: Aug 28, 2026
Ingenia Therapeutics Market Cap
Ingenia Therapeutics has a market cap or net worth of 890 billion as of August 28, 2026.
Market Cap
890.00B
Enterprise Value
882.80B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
18,000.00
ChartMarket Cap Chart
Since August 18, 2026, Ingenia Therapeutics's market cap has increased from 889.51B to 890.00B, an increase of 0.06%. That is a compound annual growth rate of 2.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 890.00B | 3.75% |
| Aug 27, 2026 | 857.86B | 0.06% |
| Aug 26, 2026 | 857.37B | 4.71% |
| Aug 25, 2026 | 818.80B | 9.31% |
| Aug 24, 2026 | 749.09B | -3.93% |
| Aug 21, 2026 | 779.74B | -13.97% |
| Aug 20, 2026 | 906.32B | 30.00% |
| Aug 19, 2026 | 697.17B | -21.62% |
| Aug 18, 2026 | 889.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 210.84B |
| DreamCIS | 85.61B |
| P&K Skin Research Center | 54.36B |
| HLB bioStep | 39.85B |
| Kolmar BioTech | 37.28B |
| SLS BIO | 26.89B |
| C&R Research | 22.64B |
| DT&CRO CO. | 19.61B |